XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Treasury stock
Accumulated other comprehensive (loss) income
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2023   89,041,946        
Beginning balance at Dec. 31, 2023 $ (148,249) $ 7,312 $ 1,180,545 $ (541) $ (93) $ (1,335,472)
Treasury stock, beginning balance (in shares) at Dec. 31, 2023       (6,748,809)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Loss for the period (127,119)         (127,119)
Other comprehensive income (loss) 296       296 0
Vestings of RSUs (in shares)       502,929    
Vestings of RSUs 0   (42) $ 42    
Exercise of options (in shares)       87,822    
Exercise of stock options 185   180 $ 5    
Issuance of shares, 2022 Employee Stock Purchase Plan 558   526 $ 32    
Issuance of shares, 2022 Employee Stock Purchase Plan (in shares)       392,185    
Issuance of shares, underwritten offering, net of transaction costs (in shares)   10,411,912   3,000,000    
Issuance of shares, underwritten offering, net of transaction costs 60,506 $ 921 59,345 $ 240    
Issuance of warrants, underwritten offering, net of transaction costs 36,925   36,925      
Share-based compensation expense 4,952   4,952      
Ending balance (in shares) at Sep. 30, 2024   99,453,858        
Ending balance at Sep. 30, 2024 (171,946) $ 8,233 1,282,431 $ (222) 203 (1,462,591)
Treasury stock, ending balance (in shares) at Sep. 30, 2024       (2,765,873)    
Beginning balance (in shares) at Dec. 31, 2023   89,041,946        
Beginning balance at Dec. 31, 2023 $ (148,249) $ 7,312 1,180,545 $ (541) (93) (1,335,472)
Treasury stock, beginning balance (in shares) at Dec. 31, 2023       (6,748,809)    
Ending balance (in shares) at Dec. 31, 2024 98,861,402 101,606,376        
Ending balance at Dec. 31, 2024 $ (202,642) $ 8,425 1,283,892 $ (220) (1,421) (1,493,318)
Treasury stock, ending balance (in shares) at Dec. 31, 2024 (2,744,974)     (2,744,974)    
Beginning balance (in shares) at Jun. 30, 2024   99,453,858        
Beginning balance at Jun. 30, 2024 $ (131,670) $ 8,233 1,279,296 $ (239) (338) (1,418,622)
Treasury stock, beginning balance (in shares) at Jun. 30, 2024       (2,984,217)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Loss for the period (43,969)         (43,969)
Other comprehensive income (loss) 541       541 0
Exercise of options (in shares)       55,834    
Exercise of stock options 111   108 $ 3    
Issuance of shares, 2022 Employee Stock Purchase Plan 235   221 $ 14    
Issuance of shares, 2022 Employee Stock Purchase Plan (in shares)       162,510    
Share-based compensation expense 2,806   2,806      
Ending balance (in shares) at Sep. 30, 2024   99,453,858        
Ending balance at Sep. 30, 2024 $ (171,946) $ 8,233 1,282,431 $ (222) 203 (1,462,591)
Treasury stock, ending balance (in shares) at Sep. 30, 2024       (2,765,873)    
Beginning balance (in shares) at Dec. 31, 2024 98,861,402 101,606,376        
Beginning balance at Dec. 31, 2024 $ (202,642) $ 8,425 1,283,892 $ (220) (1,421) (1,493,318)
Treasury stock, beginning balance (in shares) at Dec. 31, 2024 (2,744,974)     (2,744,974)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Loss for the period $ (136,214)         (136,214)
Other comprehensive income (loss) 719       719 0
Vestings of RSUs (in shares)   424,379        
Vestings of RSUs $ 0 $ 41 (41)      
Exercise of options (in shares) 146,213 126,063   20,150    
Exercise of stock options $ 315 $ 12 301 $ 2    
Issuance of shares, 2022 Employee Stock Purchase Plan 271   258 $ 13    
Issuance of shares, 2022 Employee Stock Purchase Plan (in shares)       163,576    
Issuance of shares, underwritten offering, net of transaction costs (in shares)   13,031,161        
Issuance of shares, underwritten offering, net of transaction costs 42,376 $ 1,285 41,091      
Issuance of warrants, underwritten offering, net of transaction costs 50,760   50,760      
Share-based compensation expense $ 6,232   6,232      
Ending balance (in shares) at Sep. 30, 2025 112,626,731 115,187,979        
Ending balance at Sep. 30, 2025 $ (238,183) $ 9,763 1,382,493 $ (205) (702) (1,629,532)
Treasury stock, ending balance (in shares) at Sep. 30, 2025 (2,561,248)     (2,561,248)    
Beginning balance (in shares) at Jun. 30, 2025   115,080,481        
Beginning balance at Jun. 30, 2025 $ (199,184) $ 9,753 1,380,224 $ (207) (388) (1,588,566)
Treasury stock, beginning balance (in shares) at Jun. 30, 2025       (2,581,398)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Loss for the period (40,966)         (40,966)
Other comprehensive income (loss) (314)       (314) 0
Exercise of options (in shares)   107,498   20,150    
Exercise of stock options 282 $ 10 270 $ 2    
Share-based compensation expense $ 1,999   1,999      
Ending balance (in shares) at Sep. 30, 2025 112,626,731 115,187,979        
Ending balance at Sep. 30, 2025 $ (238,183) $ 9,763 $ 1,382,493 $ (205) $ (702) $ (1,629,532)
Treasury stock, ending balance (in shares) at Sep. 30, 2025 (2,561,248)     (2,561,248)